Features of session scheduling, beneficiary allocation, and allocation of additional beneficiaries at the session site have been “further refined”, Union Health Secretary Rajesh Bhushan wrote to the states.
“The vaccination drive will be further accelerated... Whatever doses of vaccine are made available, we will ensure that they reach maximum beneficiaries. This will be done soon,” said Dr V K Paul, who heads the high-level national expert group on vaccination administration.
Top government sources said that during its review meetings with the states, the Centre has also highlighted two other states -- Punjab and Chhattisgarh – over their “poor coverage” in vaccinating its priority group.
PM Modi urged people not to abandon masks, social distancing and hygiene precautions, saying they have to remain vigilant and their mantra must be “dawai bhi, kadai bhi” (get vaccinated, but take every precaution).
In phase one of the immunisation exercise, 3 crore people in the priority group of healthcare and frontline workers are to be vaccinated. On Saturday, 3,352 sessions were held, with the target of vaccinating at least 100 people each.
Detailed backend preparations up to the block level have gone into the immunisation drive, taking into account both the experience from India's Universal Immunisation Programme and the booth strategy during elections.
COVID-19 vaccine: The Health Ministry has communicated a fact-sheet about the two Covid-19 vaccines rolling out on Saturday. Here's all you need to know about exceptions, precautions and possible adverse events.
According to the Government’s blueprint, the vaccine will be offered first to healthcare workers, frontline workers and those above 50 years of age, followed by those below 50 with associated comorbidities.
PM Modi stressed on three critical aspects: ensuring data is uploaded in real time for effective monitoring of beneficiaries; curbing rumours and misinformation; and ensuring effective reporting of adverse events, if any, after vaccination.
COVID-19 vaccine: Unlike the Serum Institute of India's (SII) vaccine Covishield, Covaxin will be used only in 'clinical trial mode', where consent will be taken and side-effects monitored, the heads of AIIMS and ICMR, part of the National Covid-19 task force, told The Indian Express.
Sources told The Indian Express that during the first dry run, conducted in Andhra Pradesh, Gujarat, Punjab, and Assam – in four districts each -- it emerged that pin codes from some villages were not mapped to the Co-Win platform, the flagship digital system that will track the vaccination programme.
Police, in a report submitted to a Delhi court in August, said that Pracha “called” riot victim Irshad Ali, whose shop had been set on fire during the riots, and told him that Malik was “witness” to the incident and if he attached Malik’s complaint, it would make Ali’s case “stronger”.